Preventive Care Priorities After Age 75: Evidence-Based Approaches for Geriatric Health

Abstract

As the global population ages, preventive care for individuals over 75 years has emerged as a paramount concern in clinical practice. This review synthesizes current evidence and guideline recommendations to provide a structured approach for prioritizing preventive interventions in late-life care. With a focus on epidemiology, pathophysiology, risk stratification, and individualized management, the article addresses the balance between benefits and risks of preventive strategies in older adults, integrating recent advances and expert consensus to enhance clinical decision-making for geriatric populations.

Introduction

Preventive care in patients aged over 75 years presents unique challenges and opportunities for clinicians. As life expectancy increases, this age group represents a growing segment of healthcare users, often with complex multimorbidity and heterogeneous functional status. The aim of preventive care shifts from extending lifespan to improving quality of life, maintaining function, and avoiding iatrogenic harm. This review outlines priorities for preventive care after age 75, drawing on contemporary evidence, clinical guidelines, and geriatric principles to guide healthcare professionals in optimizing patient outcomes.

Epidemiology / Disease Burden

Globally, the proportion of individuals aged 75 and older is rising, with projections indicating a doubling by 2050. This demographic is disproportionately burdened by chronic diseases such as cardiovascular disease, cancer, diabetes, osteoporosis, and neurodegenerative disorders. Age-related frailty, polypharmacy, and geriatric syndromes further complicate the management landscape. Mortality and morbidity patterns shift in this population, with non-communicable diseases and functional decline being prominent contributors to loss of independence and healthcare utilization. Understanding disease burden is essential for tailoring preventive measures that align with patient goals and health system resources.

Pathophysiology

Aging is characterized by cumulative physiological decline affecting multiple organ systems. Cellular senescence, immunosenescence, and reduced physiological reserve increase susceptibility to infection, malignancy, and metabolic derangements. The pathophysiology of chronic diseases often differs in older adults, with atypical presentations and altered disease trajectories. For example, cardiovascular disease may manifest with less typical symptoms, while osteoporosis and sarcopenia accelerate due to hormonal changes and nutritional deficiencies. Understanding these mechanisms informs the choice and timing of preventive interventions, emphasizing the need for individualized care.

Risk Factors

Risk factors for adverse health outcomes after age 75 include both modifiable and non-modifiable elements. Age itself is a dominant risk factor, but comorbidities, cognitive impairment, functional dependence, polypharmacy, and social determinants (e.g., living alone, low socioeconomic status) play critical roles. Frailty, defined as a syndrome of decreased reserve and resistance to stressors, is a powerful predictor of mortality, hospitalization, and institutionalization. Behavioral factors such as physical inactivity, poor nutrition, and substance use further compound risks, underscoring the importance of comprehensive risk assessment in preventive care planning.

Clinical Features

Clinical presentations in older adults are often subtle or atypical, necessitating a high index of suspicion for underlying disease. Symptoms may be masked by cognitive impairment or attributed to normal aging, leading to delays in diagnosis and intervention. Geriatric syndromes—including falls, delirium, incontinence, and sensory impairment—frequently co-exist and interact, amplifying morbidity. Functional decline and loss of independence are central clinical concerns, often serving as triggers for preventive interventions aimed at preserving autonomy and quality of life.

Diagnosis

Diagnostic approaches in this age group require careful consideration of the risks and benefits of screening and assessment tools. Over-diagnosis and incidental findings may lead to overtreatment, while underdiagnosis can result in missed opportunities for intervention. Comprehensive geriatric assessment (CGA) remains the gold standard, evaluating medical, psychological, functional, and social domains. Selective screening for conditions such as hypertension, diabetes, osteoporosis, and cognitive impairment is recommended based on individual risk profiles and life expectancy, with shared decision-making integral to the process.

Treatment & Management

Management strategies prioritize interventions with demonstrated benefit in quality and length of life, tailored to the patient’s functional status, comorbidities, and preferences. Vaccination against influenza, pneumococcus, and herpes zoster remains a mainstay. Cardiovascular risk reduction through blood pressure and lipid management should be individualized, avoiding aggressive targets that may increase adverse events. Cancer screening is generally de-emphasized unless life expectancy justifies likely benefit. Falls prevention, medication review for polypharmacy, and osteoporosis management are critical components. Lifestyle interventions—nutrition, exercise, social engagement—provide multidimensional benefits and should be promoted whenever feasible.

Recent Advances / Emerging Therapies

Recent research has highlighted the role of personalized medicine and technology in geriatric preventive care. Biomarker-based risk stratification, digital health monitoring, and telemedicine have expanded the reach and precision of interventions. Novel therapeutics targeting age-related pathophysiology, such as senolytics or anti-inflammatory agents, are under investigation. There is growing emphasis on deprescribing and medication optimization to reduce polypharmacy-related harms. Integration of geroscience principles into clinical care holds promise for enhancing resilience and delaying frailty progression.

Guideline Recommendations

Major organizations, including the U.S. Preventive Services Task Force and the American Geriatrics Society, advocate for individualized preventive care in adults over 75. Recommendations emphasize shared decision-making, periodic functional assessment, and alignment of interventions with patient values and goals. Routine screening for hypertension, lipid disorders, diabetes, and osteoporosis is supported when life expectancy and functional status are favorable. Cancer screening should be selective. Annual vaccination, falls risk assessment, cognitive and depression screening, and medication review are universally recommended. Guidelines underscore the importance of team-based care and regular reassessment of preventive goals.

Conclusion

Preventive care after age 75 requires a nuanced, patient-centered approach that balances evidence-based interventions with individual goals, functional reserve, and life expectancy. The focus shifts from disease-specific targets to holistic maintenance of function and quality of life. Ongoing research and guideline updates continue to refine best practices, with an increasing role for technology and geroscience-informed strategies. Clinicians must remain vigilant to the evolving needs of this population, integrating multidisciplinary expertise and shared decision-making to optimize outcomes in geriatric preventive care.